Tag: malignant breast neoplasm

FDA Warns Again About Robotic Mastectomy, Breaks New Ground

The US Food and Drug Administration (FDA) today issued a new safety communication about the use of robotically assisted mastectomy, warning patients and physicians that...

The Robot Comes to Mastectomy, But Cancer Outcomes Data Not Attached

Clinical trials underway across the US are exploring the use of robotic surgical devices for nipple-sparing mastectomy, but are either not collecting cancer outcomes or...

Are Oncologists Liable for Pandemic-Related Treatment Delays?

Albuquerque oncologist Barbara McAneny, MD, has a patient in his 30s who experienced rectal bleeding for 6 months last year but didn’t see a physician...

Kathy O’Brien, Critic of Cancer Bell Ringing, Dies at 56

Katherine O’Brien, who lived with metastatic breast cancer for 12 years and left her mark on American cancer care, died June 19 after a rapid...

When to Stop Cancer Screening: Clinicians’ Calculus Varies

Clinicians more often use a strict age cutoff for stopping colon cancer screening than they do for stopping breast and prostate cancer screening, new data...

Hormone Pellet Safety Data ‘Not Very Reassuring at All’ for Women

Women who receive pellet hormonal therapy may be significantly more likely to have side effects such as mood swings, anxiety, breast tenderness, hair pattern change,...

Oncologists Underestimate Patients’ Use of Complementary Tx

A large percentage of cancer patients use some form of complementary and alternative medicine, typically with the goal of relieving pain and controlling the adverse...

AI Could Sharply Reduce Mammography Workload

Using artificial intelligence (AI) in breast cancer screening could reduce the workload of radiologists by 70% without reducing cancer detection, according to a study published...

IL-6 Levels Predict Distant Breast Cancer Recurrence

The inflammatory cytokine interleukin 6 may be a biomarker for distant recurrence of breast cancer among patients treated for stage II-III HER2-negative disease, investigators have...

Olaparib in BRCA+ Breast Cancer

New clinical data show that the PARP inhibitor olaparib (Lynparza, AstraZeneca/Merck) also has a place in the treatment of early stage breast cancer with BRCA...

Pandemic Leads Doctors to Rethink Unnecessary Treatment

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Covid-19 is opening the door for researchers to address a problem...

Chemoimmunotherapy in Invasive Lobular Breast Cancer

The PD-L1 inhibitor atezolizumab (Tecentriq) combined with carboplatin has shown signs of clinical activity in women with metastatic invasive lobular breast cancer (ILC) according to...

In a Possible First, Primary Care Practice Opens in Cancer Center

Dr Nicholas Petrelli Patients with cancer will now be offered primary care in the same place as they have their cancer treatment and management, in...

Plastic Surgeons Had Top Pay and Largest Bump in Pandemic

One third of plastic surgeons saw their income decline over the last year, but the specialty overall earned the most among the 29 specialties in...

Better Survival After Lumpectomy Plus RT vs Mastectomy

Overall survival and breast cancer–specific survival were consistently better for women with early breast cancer who were treated with breast conservation surgery (BCS) followed by...

Veterinarian Helps Perform ‘Unproven’ Human Surgery

Millions Paid to Resolve Multiple Claims Involving “Unproven” Knee Surgery In what’s believed to be one of the largest public payouts in recent years, the...

Quicker Fertility Rebound in Young Women With Breast Cancer

For a young woman diagnosed with breast cancer, the prospect that the treatment needed for the cancer may irreversibly impair fertility piles on distress. A...

Cancer Screening Stopped by Pandemic: Repercussions to Come?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around the world ground to a...

Patients With Cancer Need Both Doses of COVID Vax

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The first report on responses to COVID-19 vaccination among patients with...

No Benefit Seen With Everolimus in Early Breast Cancer

Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy alone, according to results of...

How Patients Decide on Surgery

Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small...

Liquid vs Tissue Biopsy in Prostate Cancer: Why Not Both?

The genomic landscape of circulating tumor DNA (ctDNA) was comparable to the landscape of tissue biopsies in a large study of patients with metastatic castration-resistant...

New Approach to Breast Screening Based on Breast Density at 40

A new approach to breast screening proposes that all women should have a baseline  evaluation of breast density by mammography at the age of 40....

Obesity ‘Clearly’ Not Tied to Worse Survival in MBC

The relationship between obesity and overweight and breast cancer has some elements of mystery. But this is not one of them: in metastatic breast cancer...

Study Flags Cardiovascular Disease in Men With Breast Cancer

Cardiovascular disease and related risk factors can be common among male breast cancer patients, suggests a small study in this rare malignancy. Among 24 male...